Melatonin: A Beacon of Hope for Migraine Sufferers

For countless people struggling with the debilitating effects of migraine, the search for effective and safe preventive treatments has been a long and grueling journey. However, a glimmer of hope has emerged in the form of melatonin, a hormone naturally produced by the body that may hold the key to reducing the frequency and severity of migraine attacks.

Migraine, a neurological disorder characterized by severe headaches and a range of accompanying symptoms, affects about 12-20% of the general population. For those who suffer from episodic migraine, the impact on quality of life can be profound, often leading to significant disruptions in daily activities. While preventive treatments such as beta blockers and anticonvulsants have been the mainstay of migraine treatment, their effectiveness is often limited, and their side effects can be concerning. In recent years, researchers have turned their attention to melatonin, a hormone closely tied to melatonin and to the body's circadian rhythms, as a possible alternative for preventive migraine treatment.

The link between melatonin and migraine lies in the complex interplay of the hypothalamus, a brain region that plays a crucial role in the pathophysiology of migraine. Melatonin, secreted by the pineal gland, is a key regulator of the body's circadian rhythms. It has been shown to have a range of biological properties that may be beneficial in preventing migraine, including antioxidant effects, regulation of neurotransmitter activity and inhibition of pain-related peptides.

In a recent randomized, double-blind clinical trial, researchers set out to study the effects of melatonin supplementation on the frequency and severity of migraine attacks. Sixty patients with episodic migraine were divided into two groups, with one group receiving 3 mg of melatonin daily and the other a placebo, in addition to a standard preventive medication. Over two months, the melatonin group experienced a significant reduction in the frequency and duration of migraine attacks compared with the placebo group. In addition, the melatonin group reported less use of acute pain medication and improvements in migraine symptoms and sleep quality.

One of the most promising aspects of melatonin as a preventive treatment for migraine is its favorable safety profile. In the study above, side effects were minimal and comparable between the melatonin and placebo groups. This finding is consistent with earlier studies, which have consistently demonstrated the safety and tolerability of melatonin supplementation in migraine patients.

A growing body of evidence suggests that melatonin may be an important addition to the arsenal of preventive treatments for episodic migraine. Its favorable safety profile, together with its effectiveness in reducing the frequency and severity of migraines, makes it an attractive option for patients and healthcare providers alike. While further research is needed to fully clarify the mechanisms underlying melatonin's benefits in preventing migraine, the future looks bright for this humble hormone in the fight against one of the most common and debilitating neurological disorders.

If you'd like to learn more about this important subject, you can do so in the most comprehensive course in the field, called Conscious Nutrition

Learn more

Sources:

1: Ashina M. Migraine. N Engl J Med. 2020;383:1866-76. doi: 10.1056/NEJMra1915327. https://www.nejm.org/doi/full/10.1056/nejmra1915327

2: Jackson JL, Kuriyama A, Kuwatsuka Y, Nickoloff S, Storch D, Jackson W, et al. Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis. PLoS One. 2019;14:e0212785. doi: 10.1371/journal.pone.0212785. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0212785

3: Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev. 2017;97:553-622. doi: 10.1152/physrev.00034.2015. https://journals.physiology.org/doi/full/10.1152/physrev.00034.2015

4: Tseng PT, Yang CP, Su KP, Chen TY, Wu YC, Tu YK, et al. The association between melatonin and episodic migraine: A pilot network meta-analysis of randomized controlled trials to compare the prophylactic effects with exogenous melatonin supplementation and pharmacotherapy. J Pineal Res. 2020;69:e12663. doi: 10.1111/jpi.12663. https://onlinelibrary.wiley.com/doi/full/10.1111/jpi.12663

5: Mehramiri A, Shalilahmadi D, Mohamadianinejad SE, Kouti L, Hosseinpour Y. The Effect of Melatonin on Reducing the Frequency and Severity of Migraine Attacks: A Double-Blind, Randomized Clinical Trial. Iran J Med Sci. 2024;49:313-21. doi: 10.30476/ijms.2023.97782.2965. 

6: Long R, Zhu Y, Zhou S. Therapeutic role of melatonin in migraine prophylaxis: A systematic review. Medicine (Baltimore). 2019;98:e14099. doi: 10.1097/MD.0000000000014099. https://journals.lww.com/md-journal/Fulltext/2019/02220/Therapeutic_role_of_melatonin_in_migraine.44.aspx

7: Srinivasan V, Lauterbach EC, Ho KY, Acuna-Castroviejo D, Zakaria R, Brzezinski A. Melatonin in antinociception: its therapeutic applications. Curr Neuropharmacol. 2012;10:167-78. doi: 10.2174/157015912800604489. https://www.eurekaselect.com/article/40593

8: Kelman L, Rains JC. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache. 2005;45:904-10. doi: 10.1111/j.1526-4610.2005.05159.x. https://headachejournal.onlinelibrary.wiley.com/doi/full/10.1111/j.1526-4610.2005.05159.x